Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Description

This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.

Conditions

SARS- CoV-2, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Chronic Disease, Stroke

Talk to us

Study Overview

On this page

Study Details

Study overview

This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads Through Interventions Targeting Social and Structural Health Inequities.

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Condition
SARS- CoV-2
Intervention / Treatment

-

Contacts and Locations

Columbia

University of South Carolina, Columbia, South Carolina, United States, 29208

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * African American
  • * Male and female
  • * Living in a Medically Underserved Area of South Carolina; rural
  • * ≥ 18 years and above
  • * A history of a COVID-19-associated hospitalization since March 11th 2020
  • * A previous diagnosis of one or more of the following conditions: type 2 diabetes, hypertension, cardiovascular disease, chronic kidney disease, or stroke (\>3 months)
  • * Male and female
  • * ≥ 18 years and above
  • * Must live on same property or community preferably within 20-mile radius as the survivor
  • * Primarily responsible for care provision/ care support in the home (i.e., is not paid for services)
  • * Survivor and Carepartner exclusion criteria • Enrolled in related clinical trials

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of South Carolina,

Gayenell S Magwood, PhD, PRINCIPAL_INVESTIGATOR, University of South Carolina

Study Record Dates

2026-06-30